{"nct_id":"NCT04428333","title":"Study of GSK3359609 With Pembrolizumab and 5-fluorouracil (5-FU)-Platinum Chemotherapy in Participants With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma","status":"TERMINATED","status_verified_date":"2024-09","start_date":"2020-08-12","start_date_type":"ACTUAL","primary_completion_date":"2021-04-27","primary_completion_date_type":"ACTUAL","completion_date":"2023-09-19","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["GSK"]}